1996
DOI: 10.1016/s0190-9622(96)90693-3
|View full text |Cite
|
Sign up to set email alerts
|

Sweet's syndrome induced by granulocyte colony-stimulating factor in a woman with congenital neutropenia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
20
0

Year Published

1999
1999
2010
2010

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 37 publications
(20 citation statements)
references
References 26 publications
0
20
0
Order By: Relevance
“…SS has been understood as a direct response to mechanical and chemical irritants, as an infectious disease, or as a disorder of neutrophilic chemotaxis and/or phagocytosis, but often it has been described as a hypersensitivity reaction. 2–15 In this sense, histologic, immunohistochemical and immunofluorescence microscopy studies have supported a type III hypersensitivity reaction and a T cell‐dependent cellular immune reaction 11–19 . 23 Among those drug‐induced cases reported in the literature, the average time from the initiation of drug therapy to the onset of clinical symptoms, is found to be around 7.5 days.…”
Section: Discussionmentioning
confidence: 96%
See 1 more Smart Citation
“…SS has been understood as a direct response to mechanical and chemical irritants, as an infectious disease, or as a disorder of neutrophilic chemotaxis and/or phagocytosis, but often it has been described as a hypersensitivity reaction. 2–15 In this sense, histologic, immunohistochemical and immunofluorescence microscopy studies have supported a type III hypersensitivity reaction and a T cell‐dependent cellular immune reaction 11–19 . 23 Among those drug‐induced cases reported in the literature, the average time from the initiation of drug therapy to the onset of clinical symptoms, is found to be around 7.5 days.…”
Section: Discussionmentioning
confidence: 96%
“… 1 It is an uncommon acute disorder frequently associated with a great variety of diseases, such us underlying malignancies (mainly hematological), autoimmune and inflammatory disorders, previous respiratory or gastrointestinal infections and pregnancy 2,3 . Infrequently, it has been also atributed to medications, including trimethoprim‐sulfamethoxazole, 4 minocycline, 5,6 oral contraceptives, 7 all‐ trans‐ retinoic acid, 8,9 , 10 granulocyte colony‐stimulating factor, 11,12 , 13,14 furosemide, 15 hydralazine, 16 lithium, 17 diclofenac, 18 and nitrofurantoine. 19…”
Section: Discussionmentioning
confidence: 99%
“…Several cases of Sweet’s syndrome during or following G-CSF therapy have been reported [10]. The association between G-CSF therapy and Sweet’s syndrome is interesting in that G-CSF acts primarily to stimulate neutrophils, which constitute the dermal infiltrates seen in Sweet’s syndrome.…”
Section: Discussionmentioning
confidence: 99%
“…Recently, there have been several reports of Sweet's syndrome most probably related to the administration of G-CSF for neutropenia. 1 As G-CSF is frequently used for neutropenia caused by chemotherapy for urological malignancy, this disease might be on the increase.…”
Section: Introductionmentioning
confidence: 99%
“…Recently, there have been several reports of Sweet's syndrome in patients with G-CSF administration for MDS. 1 Another study reported that the patient with Sweet's syndrome showed a marked elevation of serum G-CSF, paralleling the extent of the disease. Thus, G-CSF appears to be associated with the onset of Sweet's syndrome, although the exact mechanism is still unknown.…”
mentioning
confidence: 98%